Seresto and Bravecto protect dogs and cats against fleas and ticks, but they do it in fundamentally different ways: Seresto is a slow-release collar that spreads pesticide across the skin and coat, while Bravecto is an oral chewable (or topical spot-on for cats) that enters the bloodstream and kills parasites when they bite. That core difference in delivery shapes almost everything pet owners care about, from how fast each product kills a tick to how it behaves around water, children, and other pets in the household.
How the Two Products Actually Work
Seresto is a polymer-matrix collar containing two active ingredients: imidacloprid, which targets fleas, and flumethrin, which targets ticks. These chemicals are embedded in the collar material and released slowly over months, spreading through the natural oils of the skin and fur. Because the active ingredients sit on and within the skin’s surface layer rather than circulating internally, Seresto is classified as a cutaneously distributed (topical) product. This external distribution means its compounds can contact a parasite before the parasite even bites.
Bravecto’s active ingredient is fluralaner, a member of the isoxazoline drug class. After your dog chews the flavored tablet, fluralaner is absorbed through the gut, enters the bloodstream, and reaches concentrations in the skin and tissues that are lethal to fleas and ticks. The parasite has to bite and begin feeding to ingest the drug. This is the key pharmacological distinction: Seresto can repel and kill on contact, while Bravecto requires a blood meal to deliver its payload.
Speed of Kill Against Ticks
If your main worry is ticks latching onto your dog and potentially transmitting disease, speed of kill matters a lot. Tick-borne pathogens like the bacteria behind Lyme disease generally need the tick to be attached and feeding for many hours before transmission occurs, so a product that kills or repels ticks within the first several hours offers a meaningful safety margin.
A controlled laboratory trial directly compared Seresto and Bravecto against two common North American tick species, the American dog tick and the lone star tick. At six hours after dogs were infested with ticks, the Seresto collar achieved between 94% and 100% efficacy. Bravecto, by contrast, showed just 4% to 69% efficacy at the same six-hour mark. By twelve hours, Seresto remained at 94% to 100%, while Bravecto’s efficacy ranged widely from 8% to 100% depending on the tick species and the time point in the study. Live tick counts at six hours were significantly lower on collar-wearing dogs than on Bravecto-treated dogs across every challenge day in the trial.1PubMed. Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Fluralaner Chewable Tablet (Bravecto®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial
The reason for the gap is straightforward. Seresto’s flumethrin sits in the fur and skin oils, so a tick crawling through the coat contacts lethal concentrations before it ever pierces the skin. Fluralaner, circulating in the blood, only reaches the tick after it has started feeding. That feeding delay explains the weaker six-hour numbers. Over a full 24 to 48 hours, Bravecto eventually catches up and kills the vast majority of attached ticks, but those first hours are where the collar has a clear edge.
How Long Each Product Lasts
Seresto is labeled for up to eight months of flea and tick protection on dogs. You put the collar on and, in theory, do not think about parasite prevention again until the next collar is due. Bravecto’s chewable tablet for dogs is labeled for 12 weeks of protection, meaning roughly three doses per year compared to one or two collars.
In practice, duration depends on conditions. A field trial in Cambodia comparing Seresto against a monthly topical found that the collar maintained meaningful acaricidal activity throughout its labeled period, but real-world performance can be affected by coat length, how much the dog swims, and whether the collar fits properly.2Current Research in Parasitology & Vector-Borne Diseases. Field trial investigating the efficacy of a long-acting imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto®, Elanco) compared to monthly topical fipronil for the chemoprevention of canine tick-borne pathogens in Cambodia Bravecto’s systemic distribution sidesteps external factors like water or grooming, but the trade-off is that you need to remember to re-dose every three months.
Owner compliance is one of the underappreciated variables in parasite prevention. A review of ectoparasiticide performance noted that maintaining high efficacy throughout the retreatment interval and owner adherence to the recommended protocol are both critical to reducing the risk of pathogen transmission.3Parasites & Vectors. Systemically and cutaneously distributed ectoparasiticides: a review of the efficacy against ticks and fleas on dogs A collar you never take off has a compliance advantage over a quarterly chew you might forget to buy.
Water, Bathing, and Active Dogs
Because Seresto works by distributing chemicals through the skin’s lipid layer, anything that strips those oils can reduce efficacy. Frequent swimming, medicated baths, or heavy shampooing can wash away some of the active ingredient. Elanco states the collar remains effective after occasional water exposure but recommends removing it before frequent or prolonged swimming and notes efficacy against ticks may be shortened to five months in dogs bathed monthly or exposed to water often.
Bravecto has a natural advantage here. Once fluralaner is absorbed into the bloodstream, no amount of bathing or swimming washes it out. For dogs that live near water, hunt in swamps, or get bathed regularly for skin conditions, a systemic product avoids the question entirely. The same review that examined both delivery approaches acknowledged that a systemically distributed acaricide can offer protection that is at least as effective as a topical one when factors like uniform body coverage and resistance to environmental washoff are considered.4Parasites & Vectors. Systemically and cutaneously distributed ectoparasiticides: a review of the efficacy against ticks and fleas on dogs
Safety Profiles and Side Effects
Neither product is free of reported adverse events, but the types of side effects reflect how each one works.
Seresto’s most common issues are local skin reactions. A field study in cats found that licking around the collar area and minor skin lesions occurred primarily in the first two weeks of wear, with licking being more frequent in cats wearing the active collar than in those wearing a placebo collar. One cat in that study developed localized skin inflammation severe enough to warrant removal.5PubMed Central. Field comparison of tolerance of a collar containing 10.0% imidacloprid/4.5% flumethrin (Seresto) and a placebo collar placed on cats In dogs, contact dermatitis, hair loss around the collar, and occasionally vomiting have been reported. Seresto has also attracted regulatory scrutiny due to a large volume of consumer incident reports, though the EPA has reviewed the data and kept the product on the market with updated safety labeling.
Bravecto’s safety concerns center on the nervous system. Fluralaner works by blocking nerve signaling in parasites, and although isoxazolines are designed to be far more selective for insect receptors than mammalian ones, a small fraction of dogs appear to be susceptible to neurological side effects. In one published case, a Kooikerhondje dog developed generalized unsteadiness, muscle twitching, involuntary jerking, and difficulty swallowing roughly 24 hours after receiving Bravecto. All symptoms resolved without treatment within about 10 hours.6PubMed Central. Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog
A broader survey examining adverse event reports for isoxazoline products found that seizures and neurological effects were reported globally, and the data indicated that these neurological reactions were not limited to any single isoxazoline brand or formulation.7PubMed Central. Survey of canine use and safety of isoxazoline parasiticides The FDA issued an alert in 2018 noting the potential for neurological adverse events with all isoxazoline-class products (including Bravecto, NexGard, Simparica, and Credelio) and required updated labeling. Dogs with a history of seizures are generally considered poor candidates for any isoxazoline.
Cats and Product Availability
Both Seresto and Bravecto are available for cats, but the formulations differ. Seresto for cats is a smaller collar with the same active ingredients, while Bravecto for cats comes as a topical spot-on solution rather than a chewable. The duration of protection varies by region and by parasite. In Australia, for instance, the Seresto collar carries a registered claim of four months for tick control in dogs but eight months in cats. Bravecto’s spot-on for cats demonstrated 100% efficacy against the Australian paralysis tick for three months in a study where cats were reinfested at two-week intervals.8Current Research in Parasitology & Vector-Borne Diseases. Protecting dogs and cats against the Australian paralysis tick, Ixodes holocyclus (Acari: Ixodidae): A review of the Australian acaricide registration process
For cat owners, the collar-versus-topical decision can feel different than it does for dog owners. Many cats dislike wearing collars, and there is a risk of the collar snagging or the cat trapping its jaw under the band. Seresto collars include a breakaway safety feature to reduce strangulation risk, but some cats simply will not tolerate one. A topical spot-on like Bravecto sidesteps the collar issue entirely, though cats that groom obsessively may lick the application site before it dries.
Tick-Borne Disease Prevention
Killing ticks is one thing; preventing the diseases they carry is the end goal most owners actually care about. This is where the speed-of-kill difference becomes medically relevant. Many tick-borne pathogens need the tick to feed for a prolonged period, often 24 to 48 hours, before the pathogen moves from the tick’s gut to its salivary glands and into the host. A product that kills or repels ticks within the first several hours reduces that transmission window substantially.
The Cambodia field trial mentioned earlier offered a provocative finding on this front. At the start of that study, dogs that had previously been treated with a systemic isoxazoline product were roughly 2.7 times more likely to test positive for tick-borne pathogens compared to dogs that had been treated topically, though the confidence interval was wide enough to include no effect.9Current Research in Parasitology & Vector-Borne Diseases. Field trial investigating the efficacy of a long-acting imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto®, Elanco) compared to monthly topical fipronil for the chemoprevention of canine tick-borne pathogens in Cambodia This was a single field observation in a tropical setting with very high tick pressure, so it is not definitive proof that topical products are always better at blocking disease. But the logic tracks: if a tick is repelled or killed before it begins feeding, there is no opportunity for pathogen transfer. If a tick has to bite and feed before encountering a systemic drug, a brief transmission window exists even when the product eventually kills the tick.
That said, Bravecto still dramatically reduces the number of live, feeding ticks on a treated dog compared to no treatment at all. The question is not whether Bravecto prevents tick-borne disease (it does, by killing most ticks before they finish feeding), but whether a contact-kill or repellent product might add a further margin of safety in very high-risk environments.
Use Beyond Fleas and Ticks
One area where Bravecto and other isoxazolines have gained ground is in treating parasitic skin diseases like demodectic mange, caused by Demodex mites. Clinical consensus guidelines from the World Association for Veterinary Dermatology list isoxazolines alongside older treatments as having demonstrated good efficacy against canine demodicosis.10PubMed. Diagnosis and treatment of demodicosis in dogs and cats: Clinical consensus guidelines of the World Association for Veterinary Dermatology In practice, many veterinary dermatologists now reach for fluralaner or a related isoxazoline as a first-line mange treatment because a single oral dose can clear a mite infestation that previously required months of dips or daily oral medication. Seresto has no comparable off-label role in treating mites, because its active ingredients are distributed on the skin surface and do not reach the follicular mites living deep in hair follicles the way a systemic drug does.
This broader antiparasitic utility can tip the balance for owners whose dogs are prone to mange or who live in areas where sarcoptic mange circulates among wildlife. A single product that handles fleas, ticks, and mites simplifies the treatment plan considerably.
Human Exposure and Household Considerations
If you share a bed with your dog or have young children who hug and wrestle with pets, the chemical residue question is worth considering. A study measuring imidacloprid and flumethrin levels in the fur of dogs wearing Seresto collars found that flumethrin was mostly undetectable, while imidacloprid levels were well below adult toxicity thresholds. However, concentrations were highest right after the collar was applied and could potentially reach up to about 12% of an eight-kilogram child’s acceptable daily intake. The researchers recommended limiting prolonged contact with pets, especially for young children, in the first 48 hours after putting on a new collar.11PubMed. Antiparasitic Collars: Concentration Levels of Imidacloprid and Flumethrin in Dog Fur Suggest Low Toxicity Risks for Adult Humans
That same study also detected residual imidacloprid on dog fur before a new collar was applied and a month after removal, raising questions about environmental contamination. Neonicotinoids like imidacloprid are well documented as harmful to pollinators and aquatic invertebrates, and roaming pets wearing these collars could deposit residues in gardens and waterways. For households that are environmentally conscious or keep bees, that is a factor worth weighing.
Bravecto’s active ingredient circulates internally, so fur residue is minimal. A child petting or hugging a Bravecto-treated dog is not contacting significant levels of fluralaner on the coat. The chemical does show up in feces and can persist in the environment, but the surface-contact exposure pathway that concerns parents of toddlers is largely absent with an oral product.
Cost and Practical Decision-Making
Seresto collars typically retail between $60 and $75 for a single collar lasting up to eight months. Bravecto chewables for dogs run roughly $45 to $65 per dose, with each dose covering 12 weeks. Over a full year, the math often works out to roughly similar total costs, though prices vary by retailer, pet weight class, and whether your veterinarian offers bundled pricing. Generic or counterfeit Seresto collars have been a persistent problem in online marketplaces, so purchasing from a veterinarian or an authorized retailer matters more for the collar than it does for a prescription chewable.
The practical choice often comes down to your dog’s lifestyle and your household situation. Dogs that swim frequently, get bathed often, or have sensitive skin around the neck tend to do better on an oral product. Dogs in very high tick-pressure areas where preventing any tick attachment is critical, or dogs with a seizure history who should avoid isoxazolines, are better candidates for the collar. Multi-dog households where one dog might chew another’s collar also lean toward oral dosing for simple safety reasons.
When Both Products Fall Short
No single flea and tick product covers every scenario perfectly. Seresto does not protect against heartworm, intestinal parasites, or mites, meaning most dogs still need additional preventive medications. Bravecto covers fleas, ticks, and (off-label) certain mites, but also does not prevent heartworm or intestinal worms. Some combination products on the market bundle an isoxazoline with a heartworm preventive, which can reduce the total number of products a dog receives. Seresto has no equivalent all-in-one option since it is a standalone collar.
There is also the question of regional tick species. Efficacy data for both products tends to be strongest against the most common North American and European tick species. Dogs traveling to regions with less-studied tick populations, or dogs in areas where resistance to older insecticide classes is documented, may need a conversation with a local veterinarian who understands regional parasite pressures. The broad principle that topical products repel while systemic products require a bite holds regardless of geography, but the specific efficacy percentages can shift depending on the tick species involved.